Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Retained Earnings of -$841.1 million for Q1 2026, down 332360.87% year-over-year from N/an in Q1 2025, and down 2051426.83% quarter-over-quarter from -$41000.0 in Q4 2025.
Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026) Analysis & Trends
Assembly Biosciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$841.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 332360.87% year-over-year to -$841.1 million; the TTM figure through Mar 2026 stood at -$841.1 million (down 332360.87% YoY), while the FY2025 annual figure was -$41000.0, up 100.0% from the prior year.
- Retained Earnings for Q1 2026 stood at -$841.1 million, down from -$41000.0 in the prior quarter.
- The five-year high for Retained Earnings was -$41000.0 in Q4 2025, with the low at -$844.9 million in Q2 2025.
- The 5-year median for Retained Earnings is -$513000.0 (2023), against an average of -$317.0 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings slumped 1019560.49% in 2024, then surged 100.0% in 2025.
- Assembly Biosciences' Retained Earnings stood at -$724.5 million in 2022, then surged by 99.99% to -$81000.0 in 2023, then plunged by 1019560.49% to -$825.9 million in 2024, then soared by 100.0% to -$41000.0 in 2025, then tumbled by 2051426.83% to -$841.1 million in 2026.
- Business Quant data shows ASMB's Retained Earnings at -$841.1 million in Q1 2026, -$41000.0 in Q4 2025, and -$90000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | -844.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -844.98 Mn |
| Mar 31, 2026 | -841.13 Mn |
| Dec 31, 2025 | -41,000.00 |
| Sep 30, 2025 | -90,000.00 |
| Jun 30, 2025 | -844.94 Mn |
| Mar 31, 2025 | -253,000.00 |
| Dec 31, 2024 | -825.93 Mn |
| Sep 30, 2024 | -815.59 Mn |
| Jun 30, 2024 | -293,000.00 |
| Mar 31, 2024 | -239,000.00 |
| Dec 31, 2023 | -81,000.00 |
| Sep 30, 2023 | -275,000.00 |
| Jun 30, 2023 | -325,000.00 |
| Mar 31, 2023 | -513,000.00 |
| Dec 31, 2022 | -724.52 Mn |
| Sep 30, 2022 | -999,000.00 |
| Jun 30, 2022 | -678.98 Mn |
| Mar 31, 2022 | -654.52 Mn |
| Dec 31, 2021 | -419,000.00 |
| Sep 30, 2021 | -288,000.00 |